A prospective, non interventional, trial evaluating the diagnostic accuracy of FBLN3 for Mesothelioma pleural effusions

Awarded By

New York University School of Medicine

Contributors

Harpole Jr., David Harold Principal Investigator

Start/End

September 1, 2021 - March 31, 2022